Clinical Trials Directory

Trials / Completed

CompletedNCT02036177

Multivariate Assessment of the IUB Intrauterine Device Compared With a T380A IUD

A Prospective, Randomized, Single Blind, Two Arms Controlled Study to Confirm the Safety and Verify Performance of the IUB™ SCu300A Intrauterine Device in Comparison to TCu380 IUD Intra-uterine Contraceptive Device

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
366 (actual)
Sponsor
Ocon Medical Ltd. · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The novel SCu300A IUB™ (hereafter IUB™) will be evaluated for safety and effectiveness in comparison with a market approved standard T shaped IUD containing 380sq.mm. of copper. The Primary Endpoints for comparison are based on the objective and subjective parameters. The objective parameters are pregnancy rate, perforation, expulsion and mal -position rates, changes in the endometrial thickness, rate of complications such as infection and anemia and discontinuation rates after 2 years. The subjective parameters including Quality of Life (QoL) are: pain during insertion, menstrual characteristics and pain, bleeding in correlation to the bleeding pattern prior to insertion. The Secondary Endpoints are physician opinion (ease of use in insertion and removal) and subject satisfaction.

Conditions

Interventions

TypeNameDescription
DEVICESCu300A IUB intrauterine deviceSpherical copper IUD
DEVICET380A IUDT-shaped copper IUD

Timeline

Start date
2014-06-12
Primary completion
2017-07-15
Completion
2017-07-15
First posted
2014-01-14
Last updated
2018-07-06

Locations

2 sites across 2 countries: Bulgaria, Romania

Source: ClinicalTrials.gov record NCT02036177. Inclusion in this directory is not an endorsement.